Afuco™ Anti-Human GNRHR ADCC Therapeutic Antibody, ADCC Enhanced
Anti-GNRHR ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Monoclonal antibodies against gonadotropin releasing hormone (GnRH) receptor induce cellular apoptosis of various cancer cells expressing this surface receptor. The monoclonal antibodies can serve as anti-cancer agents for the treatment of cancer in humans, and can function as analogs of GnRH to affect regulation of reproductive functions or fertility in humans.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-312CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | GNRHR |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |